Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Single-cell multiomic analysis identifies macrophage subpopulations in promoting cardiac repair
Mingzhu Fu, … , Yulong Zhong, Shanshan Ai
Mingzhu Fu, … , Yulong Zhong, Shanshan Ai
Published August 27, 2024
Citation Information: J Clin Invest. 2024;134(19):e175297. https://doi.org/10.1172/JCI175297.
View: Text | PDF
Research Article Cardiology

Single-cell multiomic analysis identifies macrophage subpopulations in promoting cardiac repair

  • Text
  • PDF
Abstract

Cardiac mononuclear phagocytic cells (Cardiac MPCs) participate in maintaining homeostasis and orchestrating cardiac responses upon injury. However, the function of specific MPC subtypes and the related cell fate commitment mechanisms remain elusive in regenerative and nonregenerative hearts due to their cellular heterogeneities. Using spatiotemporal single-cell epigenomic analysis of cardiac MPCs in regenerative (P1) and nonregenerative (P10) mouse hearts after injury, we found that P1 hearts accumulate reparative Arg1+ macrophages, while proinflammatory S100a9+Ly6c+ monocytes are uniquely abundant during nonregenerative remodeling. Moreover, blocking chemokine CXCR2 to inhibit the specification of the S100a9+Ly6c+-biased inflammatory fate in P10 hearts resulted in elevated wound repair responses and marked improvements in cardiac function after injury. Single-cell RNA-Seq further confirmed an increased Arg1+ macrophage subpopulation after CXCR2 blockade, which was accomplished by increased expression of wound repair–related genes and reduced expression of proinflammatory genes. Collectively, our findings provide instructive insights into the molecular mechanisms underlying the function and fate specification of heterogeneous MPCs during cardiac repair and identify potential therapeutic targets for myocardial infarction.

Authors

Mingzhu Fu, Shengtao Jia, Longhui Xu, Xin Li, Yufang Lv, Yulong Zhong, Shanshan Ai

×

Figure 7

Targeting S100a9+Ly6c+ C6 cells by inhibition of CXCR2 improves heart function after MI.

Options: View larger image (or click on image) Download as PowerPoint
Targeting S100a9+Ly6c+ C6 cells by inhibition of CXCR2 improves heart fu...
(A) Schematic representation of targeting S100a9+Ly6c+ IMos experimental design. SB225002 (SB) or vehicle (V) was i.p. injected for 3 days immediately after P10 MI. (B) Flow cytometry showing the percentage of S100A9+CXCR2+ IMos in each treatment group in A. (C) Representative immunostaining and quantification of S100A9+CXCR2+F4/80+ cells in the IZ of P10-MI_3D hearts injected with SB225002 (SB) or vehicle (V). Scale bar: 50 μM. (D) Masson trichrome staining of cross sections from hearts injected with SB225002 (SB) or vehicle (V) and quantification analysis. Scale bar: 200 μM. (E) Echocardiographic measurements of heart function at 1- and 3 weeks post P10 MI. The P value was determined by 1-way ANOVA with post hoc Dunnett’s test (B and E), and unpaired 2-tailed Student’s t test (C and D). Data represent mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts